<DOC>
	<DOCNO>NCT01852864</DOCNO>
	<brief_summary>The biological effect castration prostate cancer study administration degarelix prior radical prostatectomy . The effect study analysis gene expression immunohistochemistry focus marker proliferation apoptosis sample take time radical prostatectomy ( 7 day administration degarelix ) . Tumours patient treat neo-adjuvant degarelix compare tumour patient medically castrate .</brief_summary>
	<brief_title>Degarelix Before Radical Prostatectomy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<criteria>Intermediate/high risk prostate cancer Patient eligible want surgery Inability consent Previous thromboembolism/arrhythmias contraindication degarelix surgery</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>testosterone</keyword>
	<keyword>castration</keyword>
	<keyword>degarelix</keyword>
	<keyword>proliferation</keyword>
</DOC>